Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a leading treatment for advanced ovarian cancer, significantly improving overall survival and disease-free survival. This case involves a patient with peritoneal metastasis and ultra-high intra-abdominal p...
Saved in:
| Main Authors: | Suli Chen, Yanjun Lin, Shuncai Gao, Shuo Liu, Zhanmin Yang, Ruiqing Ma, Liangyuan Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1449171/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes
by: Mehdi Karimi, et al.
Published: (2024-12-01) -
Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: a six-year retrospective study
by: Guang Yang, et al.
Published: (2024-11-01) -
Advances in the Treatment of Colorectal Cancer with Peritoneal
Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal
Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01) -
Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
by: Xin Zhao, et al.
Published: (2023-02-01) -
Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery
by: Goder Noam, et al.
Published: (2024-10-01)